Table 3.
Fasting blood parameters from experimental protocol 2
| Fasting Blood Parameter | Wild-Type Sedentary | eET-1 Sedentary | Wild-Type Exercise | eET-1 Exercise | ANOVA |
|---|---|---|---|---|---|
| Cholesterol, mg/dL | 152.9 ± 15.3 | 130.8 ± 7.4 | 94.3 ± 4.8 | 103.1 ± 8.0 | G × E: NS G: NS E: P < 0.05 |
| Triglycerides, mg/dL | 138.2 ± 7.7 | 131.3 ± 3.7 | 115.7 ± 6.5 | 125.6 ± 8.3 | G × E: NS G: NS E: P < 0.05 |
| HDL, mg/dL | 61.7 ± 2.7 | 58.8 ± 2.1 | 49.6 ± 2.0 | 53.7 ± 3.5 | G × E: NS G: NS E: P < 0.05 |
| LDL, mg/dL | 91.1 ± 12.9 | 72.1 ± 5.8 | 44.7 ± 3.2 | 49.4 ± 4.7 | G × E: NS G: NS E: P < 0.05 |
| NEFA, mmol/L | 0.35 ± 0.06 | 0.29 ± 0.03 | 0.27 ± 0.04 | 0.27 ± 0.03 | G × E: NS G: NS E: NS |
| Insulin, ng/dL | 2.9 ± 0.3 | 3.1 ± 0.3 | 1.7 ± 0.2 | 2.0 ± 0.3 | G × E: NS G: NS E: P < 0.05 |
| Glucose, mg/dL | 277.1 ± 43.8 | 247.8 ± 11.7 | 216.2 ± 15.9 | 220.1 ± 23.8 | G × E: NS G: NS E: NS |
Values are means ± SE. Bold values indicate statistical significance. E, main effect of exercise; eET-1, endothelial cell-specific human prepro-endothelin-1; G, main effect of genotype; G × E; genotype × exercise interaction; NEFA, nonesterified fatty acid; NS, nonsignificant (P > 0.05).